[HTML][HTML] Triglyceride-rich lipoprotein, remnant cholesterol, and apolipoproteins CII, CIII and E in patients with schizophrenia
J Wang, M Kockx, M Bolek, T Lambert, D Sullivan… - Journal of Lipid …, 2024 - Elsevier
Patients with schizophrenia show a disproportionally increased risk of cardiovascular
disease. Hypertriglyceridemia is prevalent in this population, however how this relates to …
disease. Hypertriglyceridemia is prevalent in this population, however how this relates to …
Identification of serum metabolic traits of AIWG in first-episode schizophrenia patients
S Zhang, Z Zhai, T Gao, X Kuai, X Li, Y Dong, C Lu… - BMC psychiatry, 2024 - Springer
Background Antipsychotic-induced weight gain (AIWG) is a common side effect of
antipsychotic drugs and may lead to cardiometabolic comorbidities. There is an urgent …
antipsychotic drugs and may lead to cardiometabolic comorbidities. There is an urgent …
[HTML][HTML] Discordance Between Triglycerides, Remnant Cholesterol and Systemic Inflammation in Patients with Schizophrenia
J Wang, M Kockx, GJ Pennings, T Lambert, V Chow… - Biomedicines, 2024 - mdpi.com
Background/Objectives: Hypertriglyceridaemia and systemic inflammation are prevalent in
patients with schizophrenia and contribute to an increased risk of cardiovascular disease …
patients with schizophrenia and contribute to an increased risk of cardiovascular disease …
Pharmacogenetic Study of Antipsychotic-Induced Lipid and BMI Changes in Chinese Schizophrenia Patients: A Genome-Wide Association Study
Second-generation antipsychotics (SGAs) are widely used to treat schizophrenia (SCZ), but
they often induce metabolic side effects, including dyslipidemia and obesity, posing …
they often induce metabolic side effects, including dyslipidemia and obesity, posing …